Ozone Chemistry

The recent Opinion essay by S. Fred Singer on the awarding of the Nobel Prize in chemistry for research on chlorofluorocarbon-ozone chemistry [The Scientist, March 4, 1996, page 9] is a continuation of a well-orchestrated political campaign, using a small group of self-appointed "skeptics," that is aimed at undermining research into environmental problems. The implication that it is the Nobel Prize committee that is politicizing the basic science issues of CFC-ozone chemistry is disingenuous at

Written byPatrick Hassett
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The recent Opinion essay by S. Fred Singer on the awarding of the Nobel Prize in chemistry for research on chlorofluorocarbon-ozone chemistry [The Scientist, March 4, 1996, page 9] is a continuation of a well-orchestrated political campaign, using a small group of self-appointed "skeptics," that is aimed at undermining research into environmental problems. The implication that it is the Nobel Prize committee that is politicizing the basic science issues of CFC-ozone chemistry is disingenuous at best. Time and again the mode of attack is to assert that the basic science being conducted is contaminated by the political ends desired. The CFC-ozone and climate change research programs are the current favored targets of these "skeptics"; as species and habitat protection threatens unrestricted property use, I would guess that biodiversity and sustainability research will soon be targeted as well.

The debate is not being waged in the scientific literature or at scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies